Latest papers

Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up.

[Epidemiology and treatment of amyotrophic lateral sclerosis].

Toward a better understanding of amyotrophic lateral sclerosis.

Direct effects of riluzole on 5-hydroxytryptamine (5-HT)3 receptor-activated ion currents in NCB-20 neuroblastoma cells.

An association study of riluzole serum concentration and survival and disease progression in patients with ALS.

Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.

Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype.

Thalidomide causes sinus bradycardia in ALS.

Openers of calcium-activated potassium channels and endothelium-dependent hyperpolarizations in the guinea pig carotid artery.

Local oscillations of spiking activity in organotypic spinal cord slice cultures.

Diagnosis and management of motor neurone disease.

Motor neuron disease associated with multiple myeloma.

In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity.

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.

Eupnea of in situ rats persists following blockers of in vitro pacemaker burster activities.

Neuroprotection and repair.

Transition between two excitabilities in mesencephalic V neurons.

Molecular insights and therapeutic targets in amyotrophic lateral sclerosis.